Search - tctmd.com

Displaying 81 - 93 of 93

Sort: Relevancy | Date

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

L.A. McKeown

February 19, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Conference News ISET 2019

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Caitlin E. Cox

February 07, 2019

Presentation ISET 2019

TOBA II 12-Month Results: Tack Optimized Balloon Angioplasty

Presenter: George L. Adams

January 30, 2019

News CV Team Pro

Featured Cath Lab Pro: Vivian Tamara

January 28, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Industry News

Robocath’s R-One™ robot acquired by the Medical Training & Testing Center in Rouen for future healthcare practitioner training

January 22, 2019

News Daily News

Interventional Career? Female Fellows Repelled by ‘Old Boys Club,’ Radiation Risks, and Physical Demands

Yael L. Maxwell

January 17, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Daily News

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

Yael L. Maxwell

January 09, 2019

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Kenneth Ouriel About LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

September 26, 2019

Advertisement

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

TOBA II 12-Month Results: Tack Optimized Balloon Angioplasty

Featured Cath Lab Pro: Vivian Tamara

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

Robocath’s R-One™ robot acquired by the Medical Training & Testing Center in Rouen for future healthcare practitioner training

Interventional Career? Female Fellows Repelled by ‘Old Boys Club,’ Radiation Risks, and Physical Demands

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

Dr. C. Michael Gibson Talks With Dr. Kenneth Ouriel About LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content